Mechanism of bilirubin elimination in urine: insights and prospects for neonatal jaundice

Author(s):  
Mercy Thomas ◽  
Winita Hardikar ◽  
Ronda F. Greaves ◽  
David G. Tingay ◽  
Tze Ping Loh ◽  
...  

AbstractDespite a century of research, bilirubin metabolism and the transport mechanisms responsible for homeostasis of bilirubin in serum remain controversial. Emerging evidence on the hepatic membrane transporters and inherited disorders of bilirubin metabolism have contributed to a greater understanding of the various steps involved in bilirubin homeostasis and its associated excretory pathways. We discuss these recent research findings on hepatic membrane transporters and evaluate their significance on the newborn bilirubin metabolism and excretion. New insights gained speculate that a proportion of conjugated bilirubin is excreted via the renal system, as an alternative to the intestinal excretion, even in normal physiological jaundice with no associated pathological concerns. Finally, this paper discusses the clinical relevance of targeting the altered renal excretory pathway, as bilirubin in urine may hold diagnostic importance in screening for neonatal jaundice.

2019 ◽  
Vol 10 (4) ◽  
pp. 175-182
Author(s):  
Marsha Walker

RationaleStaying current with the burgeoning amount of breastfeeding research can be a daunting task. It is incumbent upon the IBCLC and other lactation care providers to be cognizant of new research and innovations in lactation support.MethodRecent products and findings regarding neonatal jaundice, hypoglycemia, mastitis, and therapeutic taping are presented.FindingsNew research findings, techniques, and products have been gathered to augment the provider's knowledge and skill set regarding a broad range of items relevant to clinical lactation practice. Most are affordable options for practitioners and parents, and represent safe and effective options for screening and treatment.


Author(s):  
Yukio Morimoto ◽  
Tomoaki Ishihara ◽  
Masaharu Takayama ◽  
Masahiko Kaito ◽  
Yukihiko Adachi

2003 ◽  
Vol 33 (3) ◽  
pp. 157-166 ◽  
Author(s):  
Steven F Candela ◽  
Theo C Manschreck

2008 ◽  
Vol 26 (1) ◽  
pp. 172-181 ◽  
Author(s):  
Dilara Jappar ◽  
Yongjun Hu ◽  
Richard F. Keep ◽  
David E. Smith

Author(s):  
Ruya Althomali ◽  
Renad Aloqayli ◽  
Basma Alyafi ◽  
Ahela Nono ◽  
Suhaib Alkhalaf ◽  
...  

80% of healthy neonates present with some degree of hyperbilirubinemia after birth, however, only 5-10% would require therapy to prevent damage or treat the cause of jaundice. Neonatal jaundice can be classified as physiological and pathological and can have several causes such as breast milk feeding, blood group incompatibility, hemolysis, or genetic defects of enzymes in the bilirubin metabolism pathway. We tried to understand the various types of neonatal jaundice, and also focus on its management. We conducted this review using a comprehensive search of MEDLINE, PubMed and EMBASE from January 2001 to March 2017. The following search terms were used: neonatal jaundice, hyperbilirubinemia, ABO incompatibility, neonatal hemolysis, kernicterus, phototherapy, exchange transfusion. Hyperbilirubinemia and jaundice are common issues encountered neonates and infants. Most cases of neonatal hyperbilirubinemia and jaundice are physiological and benign. However, some severe cases may progress to develop severe and permanent long-term complications. Therefore, early diagnosis and management is essential. Neonatal jaundice can be treated using phototherapy, pharmacological agents, intravenous immunoglobulins and exchange transfusion in severe cases.


2014 ◽  
Vol 142 (3-4) ◽  
pp. 257-260 ◽  
Author(s):  
Nedeljko Radlovic

Inherited disorders of bilirubin metabolism involve four autosomal recessive syndromes: Gilbert, Crigler- Najjar, Dubin-Johnson and Rotor, among which the first two are characterized by unconjugated and the second two by conjugated hyperbilirubinemia. Gilbert syndrome occurs in 2%-10% of general population, while others are rare. Except for Crigler-Najjar syndrome, hereditary hyperbilirubinemias belong to benign disorders and thus no treatment is required.


2020 ◽  
Vol 11 (1) ◽  
pp. 7921-7931

In neonatal jaundice, β-glucuronidase converts conjugated bilirubin into the unconjugated form and increases its level in the blood. Many natural compounds have been identified as β-glucuronidase inhibitors. The aim of this study was to evaluate the effect of hydro-methanolic extracts of 100 plants on β-glucuronidase. The β-glucuronidase activity was measured by a spectrophotometric method using Phenolphthalein glucuronide and 4-nitrophenyl β-D-glucuronide. Kinetic study of the enzyme was performed in the presence and absence of the plant extract. It was revealed that from hydro-methanolic (70%) extracts, Rosa damascena and Ipomoea tricolor showed more than 85% inhibitory effect on β-glucuronidase. Rosa damascena showed competitive inhibition, and Ipomoea tricolor showed non-competitive inhibition. The Km and Vmax values for β-glucuronidase were 23.32 mM and 0.814 mM min-1, respectively. When using 4-nitrophenyl β-D-glucuronide, Stevia and Cerasus avium showed more than 65% inhibitory effect on β-glucuronidase. Both Stevia and Cerasus avium showed non-competitive inhibition. The Km and Vmax values for β-glucuronidase were 16.98 mM and 0.936 mM min-1, respectively. None of the plant extracts showed an activation effect on the enzyme. The data suggest that these plants might be good candidates for the treatment of neonatal jaundice and its related diseases.


Sign in / Sign up

Export Citation Format

Share Document